-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

A new, first-in-class treatment for RRMM patients

Sponsor: Johnson & Johnson
Program: Product Theaters
Monday, December 11, 2023: 8:00 AM-9:00 AM
Room 5B (San Diego Convention Center)
Saurabh N. Patel, MD, Johnson & Johnson
No relevant conflicts of interest to declare.
For In-Person Participants Only
See more of: Product Theaters